|
Volumn 107, Issue 6, 2011, Pages 529-537.e2
|
Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: The FAST-3 trial
h
SHIRE
(United States)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ICATIBANT;
PLACEBO;
ABDOMINAL DISTENSION;
ABDOMINAL PAIN;
ADULT;
ANGIONEUROTIC EDEMA;
ARTICLE;
ASPHYXIA;
CALCIUM BLOOD LEVEL;
CHILL;
CHOLELITHIASIS;
CONSTIPATION;
CONTROLLED STUDY;
CREATINE KINASE BLOOD LEVEL;
DIARRHEA;
DISEASE SEVERITY;
DIZZINESS;
DOUBLE BLIND PROCEDURE;
DRUG EFFICACY;
DRUG ERUPTION;
DRUG FEVER;
DRUG INDUCED HEADACHE;
DRUG SAFETY;
DRUG TOLERABILITY;
DYSPEPSIA;
DYSPHAGIA;
DYSPHONIA;
DYSPNEA;
DYSURIA;
EDEMA;
ERYTHEMA;
ERYTHROCYTE COUNT;
FEMALE;
GASTROENTERITIS;
HEART INFARCTION;
HEART PALPITATION;
HERPES SIMPLEX;
HUMAN;
HYPERSENSITIVITY;
HYPESTHESIA;
INFUSION SITE ERYTHEMA;
INJECTION SITE ERYTHEMA;
INJECTION SITE PRURITUS;
INJECTION SITE REACTION;
INJECTION SITE SWELLING;
MAJOR CLINICAL STUDY;
MALE;
MULTICENTER STUDY;
NAUSEA;
OPEN STUDY;
PHARYNGITIS;
PHASE 3 CLINICAL TRIAL;
POST HOC ANALYSIS;
PRIORITY JOURNAL;
PRURITUS;
RANDOMIZED CONTROLLED TRIAL;
RHINOPHARYNGITIS;
SIDE EFFECT;
SINUS CONGESTION;
SINUSITIS;
SKIN IRRITATION;
SKIN PAIN;
SKIN SWELLING;
STRIDOR;
URINARY TRACT INFECTION;
VISUAL ANALOG SCALE;
VOICE CHANGE;
VOMITING;
|
EID: 82955233701
PISSN: 10811206
EISSN: 15344436
Source Type: Journal
DOI: 10.1016/j.anai.2011.08.015 Document Type: Article |
Times cited : (196)
|
References (9)
|